Figure 3
From: Receptor for advanced glycation end-products and ARDS prediction: a multicentre observational study
Receiver operating characteristic (ROC) curves. (A) Baseline plasma sRAGE (area under ROC curve (AUROC), 0.74; 95% CI, [0.68–0.80] and (B) plasma sRAGE on day one (AUROC, 0.82 [0.76–0.88]) each showed good discrimination between those who developed ARDS and those who did not, but (C) the LIPS was poorly discriminative in this population of patients at risk of developing ARDS (AUROC, 0.57 [0.49–0.65]).
